HRT Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
HRT Financial's JAZZ Position: Q1 2026 in Review
HRT Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 85% in Q1 2026, buying an estimated $900K and bringing the position to 11,227 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #1584.
HRT Financial first reported a position in JAZZ in Q2 2019 and has held it in 14 quarters since. The position peaked at $14.7M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- HRT Financial held 11,227 shares of Jazz Pharmaceuticals worth $2.12M as of Q1 2026.
- HRT Financial bought 5,149 Jazz Pharmaceuticals shares in Q1 2026, an estimated $900K.
- Jazz Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1584 holding.
- HRT Financial first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 14 quarters since.
- HRT Financial's Jazz Pharmaceuticals position peaked at $14.7M in Q1 2025.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.